Investors Research Corp - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 180 filers reported holding DIPLOMAT PHARMACY INC in Q3 2018. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$352,000
-18.7%
87,977
-0.4%
0.16%
-26.4%
Q3 2019$433,000
-20.7%
88,327
-1.6%
0.22%
-22.8%
Q2 2019$546,000
+2.8%
89,727
-1.8%
0.28%
+0.7%
Q1 2019$531,000
-57.1%
91,327
-0.8%
0.28%
-67.3%
Q4 2018$1,239,000
-30.6%
92,0270.0%0.86%
-15.3%
Q3 2018$1,786,000
-26.6%
92,027
-3.3%
1.02%
-27.6%
Q2 2018$2,432,000
+28.5%
95,150
+1.3%
1.41%
+22.6%
Q1 2018$1,893,000
-2.3%
93,950
-2.7%
1.15%
-4.0%
Q4 2017$1,938,00096,5501.20%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2018
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders